• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Illumina

Illumina

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  1. World $5.8 Billion Fluidigm Patent Portfolio Analysis 2017-2022 - Research and Markets

    World $5.8 Billion Fluidigm Patent Portfolio Analysis 2017-2022 - Research and Markets

  2. Global In-Vitro Diagnostics (IVD) Market Analysis and Forecast 2017-2023: Focus on Product Type, Test Type, Application, and Competitive Landscape - Research and Markets

    Global In-Vitro Diagnostics (IVD) Market Analysis and Forecast 2017-2023: Focus on Product Type, Test Type, Application, and Competitive Landscape - Research and Markets

  3. United States Non-Invasive Prenatal Testing (NIPT) Market 2017-2023 - Research and Markets

    United States Non-Invasive Prenatal Testing (NIPT) Market 2017-2023 - Research and Markets

  4. Worldwide In Vitro Diagnostics Market 2017: IVD Test Volume and Pricing Analysis - Research and Markets

    Worldwide In Vitro Diagnostics Market 2017: IVD Test Volume and Pricing Analysis - Research and Markets

  5. Infectious Disease Molecular Diagnostics Market Report 2017 - Hepatitis, HIV/CT/NG/HPV & Other Tests - Research and Markets

    Infectious Disease Molecular Diagnostics Market Report 2017 - Hepatitis, HIV/CT/NG/HPV & Other Tests - Research and Markets

  6. Transplant Matching Molecular Diagnostics Market, 2021 - Research and Markets

    Transplant Matching Molecular Diagnostics Market, 2021 - Research and Markets

  7. Tuttle Tactical Management Weekly Market Notes

    Illumina ILMN reported second-quarter results Tuesday that beat our expectations, and we plan to raise our fair value estimate by several dollars per share. Revenue totaled $84.5 million for the quarter, a 103% increase from the year-ago period, which prompted the firm to significantly raise its ...

  8. First Quarter in U.S. Equity Funds: Growth Dominates Value

    After a tough 2016, growth made a comeback in 2017's first quarter.

  9. Global Transplantation Market Projected to be Worth USD 117.89 billion by 2021: Technavio

    Global Transplantation Market Projected to be Worth USD 117.89 billion by 2021: Technavio

  10. Leader in Genomic Sequencing Illuminates the Way

    Continued technology advancements and market expansion support Illumina's narrow moat.

12

©2017 Morningstar Advisor. All right reserved.